Roundtables: Meet the 2025 Innovator of the Year
Summary
MIT Technology Review’s subscriber-only roundtable spotlights Sneha Goenka, the 2025 Innovator of the Year. Goenka designed the computational methods behind what’s billed as the world’s fastest whole-genome sequencing technique, enabling clinicians to sequence a patient’s genome and diagnose a genetic condition in under eight hours. The recorded session (23 September 2025) features Goenka in conversation with Leilani Battle (University of Washington) and Mat Honan (editor in chief).
Key Points
- Sneha Goenka named 2025 Innovator of the Year for computational work on ultra-fast whole-genome sequencing.
- The method cuts sequencing and diagnostic time to less than eight hours, which is transformative for time-critical clinical care.
- The roundtable is a subscriber-only recorded conversation including expert perspectives from Leilani Battle and Mat Honan.
- This advance is primarily a computational breakthrough that improves throughput and turn-around without necessarily depending on new lab hardware.
- Related coverage links include a longer profile on Goenka’s technology and MIT Technology Review’s Innovators Under 35 series.
Content summary
Each year MIT Technology Review picks one individual as Innovator of the Year; in 2025 that honour goes to Sneha Goenka. The article promotes a roundtable discussion (available to subscribers and MIT alumni) where Goenka discusses how she optimised the algorithms and workflows that underpin an ultra-fast sequencing pipeline. The piece highlights the clinical potential of sub-eight-hour genome sequencing for diagnosing genetic conditions rapidly and points readers to related reporting on the technology and the Innovators Under 35 list.
Context and relevance
Rapid whole-genome sequencing has been a long-standing bottleneck in bringing genomics into urgent clinical settings. By focusing on computational improvements, Goenka’s work reduces the time between sample and diagnosis, which can be critical in neonatal intensive care, rare-disease diagnosis and acute care settings. The roundtable discussion situates the breakthrough within broader trends: algorithmic optimisation, integration of sequencing into clinical workflows, and the growing role of software in accelerating biomedical advances.
Why should I read this?
Short version: if you care about genomics, healthcare tech or how software can upend lab timelines, this is worth a quick listen. The roundtable gives plain-language insight into the nuts and bolts of a real-world speed-up that could change how hospitals diagnose genetic conditions — and it’s from the person who built the computations. Subscriber-only, but highly relevant if you want to know where clinical sequencing is headed.
